Delivery Order SPE2DB22D2103-SPE2DB24FR8WL
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,792.08 firm fixed-price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 2025. The IDC serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ibrance 75 mg capsules. The contract, valued at $15,595.70, has an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp previously held an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,792.08 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of IBRANCE 125 MG CAPSULE 21S. This contract has an ultimate completion date of September 17, 2024 and was awarded on August 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several multi-million dollar Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of IBRANCE 100 MG CAPSULE 21S pharmaceutical products to the DLA, with a completion date of February 23, 2024 and a potential value of $15,592.62. The award does not have a set-aside designation....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $14,969.50 contract is for the delivery of IBRANCE 125 MG CAPSULE 21S pharmaceutical product to support military treatment programs and facilities. Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution company, has an extensive history of providing pharmaceutical and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, with a potential value of $7,792.08 and a performance period through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,061.38 firm fixed-price delivery order is for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,127.13 firm fixed-price delivery order is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,248,339 units of IBRANCE 100 MG CAPSULE 21S. The $14,977.62 contract has a performance period through January 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously supplied pharmaceuticals, medical supplies, and distribution services to DLA under multiple awards. This latest...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, for the provision of 4563692603 IBRANCE 100 MG TABLET 7S medication. The contract, valued at $7,796.30, has a completion date of March 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. This award is likely part...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB24FR8WLDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $38,960.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of IBRANCE 125 MG CAPSULE 21S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00, that serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide. Amerisourcebergen Drug Corp is a for-profit organization that specializes in pharmaceutical sourcing and distribution services. This delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.0k | 2/6/24 |